Importantly, hepcidin expression was significantly correlated with the tumor mutation burden (TMB), tumor microenvironment (TME), immunosuppressant targets and tumor immune dysfunction and exclusion (TIDE) scores. The gene discussed is HAMP; the disease is neoplasm.